nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—KCNJ11—Verapamil—migraine	0.289	0.378	CbGbCtD
Repaglinide—SLCO1B1—Verapamil—migraine	0.115	0.15	CbGbCtD
Repaglinide—ALB—Amitriptyline—migraine	0.0792	0.104	CbGbCtD
Repaglinide—CYP2C8—Amitriptyline—migraine	0.0612	0.0801	CbGbCtD
Repaglinide—CYP2C8—Valproic Acid—migraine	0.0558	0.073	CbGbCtD
Repaglinide—CYP2C8—Verapamil—migraine	0.0486	0.0635	CbGbCtD
Repaglinide—CYP3A4—Propranolol—migraine	0.0287	0.0375	CbGbCtD
Repaglinide—CYP3A4—Amitriptyline—migraine	0.0248	0.0325	CbGbCtD
Repaglinide—CYP3A4—Valproic Acid—migraine	0.0226	0.0296	CbGbCtD
Repaglinide—CYP3A4—Topiramate—migraine	0.0204	0.0267	CbGbCtD
Repaglinide—CYP3A4—Verapamil—migraine	0.0197	0.0258	CbGbCtD
Repaglinide—PPARG—Differentiation of white and brown adipocyte   —PRDM16—migraine	0.00542	0.163	CbGpPWpGaD
Repaglinide—KCNJ11—Type II diabetes mellitus—CACNA1A—migraine	0.00337	0.101	CbGpPWpGaD
Repaglinide—ABCC8—Potassium Channels—KCNK18—migraine	0.00214	0.0643	CbGpPWpGaD
Repaglinide—KCNJ11—Potassium Channels—KCNK18—migraine	0.00207	0.0624	CbGpPWpGaD
Repaglinide—Alopecia—Amitriptyline—migraine	0.00135	0.00668	CcSEcCtD
Repaglinide—Hepatic function abnormal—Valproic Acid—migraine	0.00134	0.00664	CcSEcCtD
Repaglinide—ALB—Scavenging of heme from plasma—LRP1—migraine	0.00134	0.0403	CbGpPWpGaD
Repaglinide—Cardiovascular disorder—Topiramate—migraine	0.00128	0.00635	CcSEcCtD
Repaglinide—ABCC8—Regulation of insulin secretion—CACNA1A—migraine	0.00128	0.0384	CbGpPWpGaD
Repaglinide—Stevens-Johnson syndrome—Verapamil—migraine	0.00127	0.00625	CcSEcCtD
Repaglinide—Acute coronary syndrome—Verapamil—migraine	0.00126	0.00622	CcSEcCtD
Repaglinide—Myocardial infarction—Verapamil—migraine	0.00125	0.00618	CcSEcCtD
Repaglinide—Jaundice—Verapamil—migraine	0.00124	0.00615	CcSEcCtD
Repaglinide—KCNJ11—Regulation of insulin secretion—CACNA1A—migraine	0.00124	0.0372	CbGpPWpGaD
Repaglinide—Visual impairment—Propranolol—migraine	0.0012	0.00593	CcSEcCtD
Repaglinide—Sinusitis—Verapamil—migraine	0.0012	0.00592	CcSEcCtD
Repaglinide—Hepatic enzyme increased—Topiramate—migraine	0.00119	0.0059	CcSEcCtD
Repaglinide—Leukopenia—Amitriptyline—migraine	0.00119	0.00589	CcSEcCtD
Repaglinide—Erythema multiforme—Propranolol—migraine	0.00118	0.00582	CcSEcCtD
Repaglinide—Palpitations—Amitriptyline—migraine	0.00118	0.00582	CcSEcCtD
Repaglinide—Cardiac disorder—Propranolol—migraine	0.00116	0.00571	CcSEcCtD
Repaglinide—Cardiac failure congestive—Timolol—migraine	0.00115	0.0057	CcSEcCtD
Repaglinide—Hypertension—Amitriptyline—migraine	0.00115	0.00568	CcSEcCtD
Repaglinide—Rhinitis—Verapamil—migraine	0.00115	0.00568	CcSEcCtD
Repaglinide—Hepatitis—Verapamil—migraine	0.00115	0.00566	CcSEcCtD
Repaglinide—Oedema peripheral—Verapamil—migraine	0.00113	0.00558	CcSEcCtD
Repaglinide—Hepatic function abnormal—Gabapentin—migraine	0.00111	0.00551	CcSEcCtD
Repaglinide—Visual impairment—Verapamil—migraine	0.0011	0.00546	CcSEcCtD
Repaglinide—Visual disturbance—Timolol—migraine	0.0011	0.00545	CcSEcCtD
Repaglinide—Alopecia—Propranolol—migraine	0.0011	0.00544	CcSEcCtD
Repaglinide—Oedema—Amitriptyline—migraine	0.00109	0.00537	CcSEcCtD
Repaglinide—Erythema—Propranolol—migraine	0.00108	0.00536	CcSEcCtD
Repaglinide—Erythema multiforme—Verapamil—migraine	0.00108	0.00535	CcSEcCtD
Repaglinide—Cardiac failure congestive—Gabapentin—migraine	0.00107	0.00531	CcSEcCtD
Repaglinide—Hypoglycaemia—Timolol—migraine	0.00107	0.00529	CcSEcCtD
Repaglinide—Thrombocytopenia—Amitriptyline—migraine	0.00106	0.00526	CcSEcCtD
Repaglinide—Alopecia—Verapamil—migraine	0.00101	0.005	CcSEcCtD
Repaglinide—ABCC8—Integration of energy metabolism—CACNA1A—migraine	0.001	0.0302	CbGpPWpGaD
Repaglinide—Hypoglycaemia—Gabapentin—migraine	0.000998	0.00493	CcSEcCtD
Repaglinide—Pancreatitis—Valproic Acid—migraine	0.000996	0.00492	CcSEcCtD
Repaglinide—Bronchitis—Valproic Acid—migraine	0.000977	0.00482	CcSEcCtD
Repaglinide—Paraesthesia—Amitriptyline—migraine	0.000976	0.00482	CcSEcCtD
Repaglinide—KCNJ11—Integration of energy metabolism—CACNA1A—migraine	0.000974	0.0293	CbGpPWpGaD
Repaglinide—Dyspepsia—Amitriptyline—migraine	0.000957	0.00473	CcSEcCtD
Repaglinide—ABCC8—Neuronal System—KCNK18—migraine	0.000934	0.0281	CbGpPWpGaD
Repaglinide—Constipation—Amitriptyline—migraine	0.00093	0.00459	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000917	0.00453	CcSEcCtD
Repaglinide—KCNJ11—Neuronal System—KCNK18—migraine	0.000905	0.0272	CbGpPWpGaD
Repaglinide—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000898	0.00443	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—PGR—migraine	0.000887	0.0267	CbGpPWpGaD
Repaglinide—Anaphylactic shock—Propranolol—migraine	0.000885	0.00437	CcSEcCtD
Repaglinide—Palpitations—Verapamil—migraine	0.000882	0.00436	CcSEcCtD
Repaglinide—Angina pectoris—Timolol—migraine	0.000881	0.00435	CcSEcCtD
Repaglinide—Urinary tract infection—Valproic Acid—migraine	0.00088	0.00435	CcSEcCtD
Repaglinide—Visual disturbance—Topiramate—migraine	0.000865	0.00427	CcSEcCtD
Repaglinide—Urticaria—Amitriptyline—migraine	0.000864	0.00427	CcSEcCtD
Repaglinide—Hypertension—Verapamil—migraine	0.000862	0.00426	CcSEcCtD
Repaglinide—Skin disorder—Propranolol—migraine	0.00086	0.00425	CcSEcCtD
Repaglinide—Hepatobiliary disease—Valproic Acid—migraine	0.000856	0.00423	CcSEcCtD
Repaglinide—Arthralgia—Verapamil—migraine	0.00085	0.0042	CcSEcCtD
Repaglinide—Chest pain—Verapamil—migraine	0.00085	0.0042	CcSEcCtD
Repaglinide—Sinusitis—Valproic Acid—migraine	0.00085	0.0042	CcSEcCtD
Repaglinide—Hypoglycaemia—Topiramate—migraine	0.00084	0.00415	CcSEcCtD
Repaglinide—Pancreatitis—Gabapentin—migraine	0.000825	0.00408	CcSEcCtD
Repaglinide—Angina pectoris—Gabapentin—migraine	0.00082	0.00405	CcSEcCtD
Repaglinide—Hyperglycaemia—Timolol—migraine	0.000816	0.00403	CcSEcCtD
Repaglinide—Rhinitis—Valproic Acid—migraine	0.000815	0.00403	CcSEcCtD
Repaglinide—Oedema—Verapamil—migraine	0.000815	0.00402	CcSEcCtD
Repaglinide—Anaphylactic shock—Verapamil—migraine	0.000815	0.00402	CcSEcCtD
Repaglinide—Bronchitis—Gabapentin—migraine	0.00081	0.004	CcSEcCtD
Repaglinide—Oedema peripheral—Valproic Acid—migraine	0.000801	0.00396	CcSEcCtD
Repaglinide—Paraesthesia—Propranolol—migraine	0.000795	0.00393	CcSEcCtD
Repaglinide—Visual impairment—Valproic Acid—migraine	0.000783	0.00387	CcSEcCtD
Repaglinide—Dyspepsia—Propranolol—migraine	0.000779	0.00385	CcSEcCtD
Repaglinide—Pruritus—Amitriptyline—migraine	0.000769	0.0038	CcSEcCtD
Repaglinide—Erythema multiforme—Valproic Acid—migraine	0.000769	0.0038	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Propranolol—migraine	0.000764	0.00378	CcSEcCtD
Repaglinide—Eye disorder—Valproic Acid—migraine	0.00076	0.00375	CcSEcCtD
Repaglinide—Hyperglycaemia—Gabapentin—migraine	0.000759	0.00375	CcSEcCtD
Repaglinide—Constipation—Propranolol—migraine	0.000757	0.00374	CcSEcCtD
Repaglinide—Sinusitis—Timolol—migraine	0.000756	0.00374	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Gabapentin—migraine	0.000744	0.00368	CcSEcCtD
Repaglinide—Diarrhoea—Amitriptyline—migraine	0.000744	0.00368	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Verapamil—migraine	0.000742	0.00367	CcSEcCtD
Repaglinide—Acute coronary syndrome—Gabapentin—migraine	0.00074	0.00366	CcSEcCtD
Repaglinide—Myocardial infarction—Gabapentin—migraine	0.000736	0.00363	CcSEcCtD
Repaglinide—Immune system disorder—Valproic Acid—migraine	0.000734	0.00363	CcSEcCtD
Repaglinide—Jaundice—Gabapentin—migraine	0.000732	0.00361	CcSEcCtD
Repaglinide—Paraesthesia—Verapamil—migraine	0.000731	0.00361	CcSEcCtD
Repaglinide—Urinary tract infection—Gabapentin—migraine	0.00073	0.0036	CcSEcCtD
Repaglinide—Arrhythmia—Valproic Acid—migraine	0.000726	0.00359	CcSEcCtD
Repaglinide—Rhinitis—Timolol—migraine	0.000725	0.00358	CcSEcCtD
Repaglinide—Gastrointestinal pain—Propranolol—migraine	0.000724	0.00358	CcSEcCtD
Repaglinide—Alopecia—Valproic Acid—migraine	0.000718	0.00355	CcSEcCtD
Repaglinide—Dyspepsia—Verapamil—migraine	0.000717	0.00354	CcSEcCtD
Repaglinide—Oedema peripheral—Timolol—migraine	0.000713	0.00352	CcSEcCtD
Repaglinide—Hepatobiliary disease—Gabapentin—migraine	0.00071	0.00351	CcSEcCtD
Repaglinide—Malnutrition—Valproic Acid—migraine	0.000708	0.0035	CcSEcCtD
Repaglinide—Sinusitis—Gabapentin—migraine	0.000704	0.00348	CcSEcCtD
Repaglinide—Urticaria—Propranolol—migraine	0.000703	0.00347	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—PGR—migraine	0.000701	0.0211	CbGpPWpGaD
Repaglinide—Abdominal pain—Propranolol—migraine	0.0007	0.00346	CcSEcCtD
Repaglinide—Visual impairment—Timolol—migraine	0.000697	0.00344	CcSEcCtD
Repaglinide—Constipation—Verapamil—migraine	0.000697	0.00344	CcSEcCtD
Repaglinide—Pancreatitis—Topiramate—migraine	0.000694	0.00343	CcSEcCtD
Repaglinide—Vomiting—Amitriptyline—migraine	0.000691	0.00342	CcSEcCtD
Repaglinide—Angina pectoris—Topiramate—migraine	0.00069	0.00341	CcSEcCtD
Repaglinide—Rash—Amitriptyline—migraine	0.000686	0.00339	CcSEcCtD
Repaglinide—Dermatitis—Amitriptyline—migraine	0.000685	0.00338	CcSEcCtD
Repaglinide—Back pain—Valproic Acid—migraine	0.000684	0.00338	CcSEcCtD
Repaglinide—Headache—Amitriptyline—migraine	0.000681	0.00337	CcSEcCtD
Repaglinide—Bronchitis—Topiramate—migraine	0.000681	0.00336	CcSEcCtD
Repaglinide—Eye disorder—Timolol—migraine	0.000676	0.00334	CcSEcCtD
Repaglinide—Rhinitis—Gabapentin—migraine	0.000676	0.00334	CcSEcCtD
Repaglinide—Hepatitis—Gabapentin—migraine	0.000674	0.00333	CcSEcCtD
Repaglinide—Cardiac disorder—Timolol—migraine	0.000672	0.00332	CcSEcCtD
Repaglinide—Oedema peripheral—Gabapentin—migraine	0.000664	0.00328	CcSEcCtD
Repaglinide—Immune system disorder—Timolol—migraine	0.000654	0.00323	CcSEcCtD
Repaglinide—Hypersensitivity—Propranolol—migraine	0.000652	0.00322	CcSEcCtD
Repaglinide—Visual impairment—Gabapentin—migraine	0.000649	0.00321	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—MEF2D—migraine	0.000647	0.0195	CbGpPWpGaD
Repaglinide—Urticaria—Verapamil—migraine	0.000647	0.0032	CcSEcCtD
Repaglinide—Arrhythmia—Timolol—migraine	0.000646	0.00319	CcSEcCtD
Repaglinide—Nausea—Amitriptyline—migraine	0.000646	0.00319	CcSEcCtD
Repaglinide—Alopecia—Timolol—migraine	0.000639	0.00316	CcSEcCtD
Repaglinide—Hyperglycaemia—Topiramate—migraine	0.000639	0.00316	CcSEcCtD
Repaglinide—Erythema multiforme—Gabapentin—migraine	0.000637	0.00315	CcSEcCtD
Repaglinide—Leukopenia—Valproic Acid—migraine	0.000633	0.00313	CcSEcCtD
Repaglinide—Malnutrition—Timolol—migraine	0.00063	0.00311	CcSEcCtD
Repaglinide—Erythema—Timolol—migraine	0.00063	0.00311	CcSEcCtD
Repaglinide—Eye disorder—Gabapentin—migraine	0.00063	0.00311	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Topiramate—migraine	0.000626	0.00309	CcSEcCtD
Repaglinide—Cardiac disorder—Gabapentin—migraine	0.000625	0.00309	CcSEcCtD
Repaglinide—Palpitations—Valproic Acid—migraine	0.000625	0.00309	CcSEcCtD
Repaglinide—Urinary tract infection—Topiramate—migraine	0.000614	0.00303	CcSEcCtD
Repaglinide—Hypertension—Valproic Acid—migraine	0.000611	0.00302	CcSEcCtD
Repaglinide—Immune system disorder—Gabapentin—migraine	0.000609	0.00301	CcSEcCtD
Repaglinide—Diarrhoea—Propranolol—migraine	0.000606	0.00299	CcSEcCtD
Repaglinide—Arthralgia—Valproic Acid—migraine	0.000602	0.00298	CcSEcCtD
Repaglinide—Chest pain—Valproic Acid—migraine	0.000602	0.00298	CcSEcCtD
Repaglinide—Hypersensitivity—Verapamil—migraine	0.0006	0.00296	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000598	0.00296	CcSEcCtD
Repaglinide—Alopecia—Gabapentin—migraine	0.000595	0.00294	CcSEcCtD
Repaglinide—Sinusitis—Topiramate—migraine	0.000592	0.00293	CcSEcCtD
Repaglinide—Malnutrition—Gabapentin—migraine	0.000587	0.0029	CcSEcCtD
Repaglinide—Erythema—Gabapentin—migraine	0.000587	0.0029	CcSEcCtD
Repaglinide—Oedema—Valproic Acid—migraine	0.000578	0.00285	CcSEcCtD
Repaglinide—Anaphylactic shock—Valproic Acid—migraine	0.000578	0.00285	CcSEcCtD
Repaglinide—Pruritus—Verapamil—migraine	0.000576	0.00285	CcSEcCtD
Repaglinide—Rhinitis—Topiramate—migraine	0.000568	0.00281	CcSEcCtD
Repaglinide—Back pain—Gabapentin—migraine	0.000567	0.0028	CcSEcCtD
Repaglinide—Hepatitis—Topiramate—migraine	0.000567	0.0028	CcSEcCtD
Repaglinide—Thrombocytopenia—Valproic Acid—migraine	0.000565	0.00279	CcSEcCtD
Repaglinide—Vomiting—Propranolol—migraine	0.000563	0.00278	CcSEcCtD
Repaglinide—Skin disorder—Valproic Acid—migraine	0.000561	0.00277	CcSEcCtD
Repaglinide—Oedema peripheral—Topiramate—migraine	0.000558	0.00276	CcSEcCtD
Repaglinide—Rash—Propranolol—migraine	0.000558	0.00276	CcSEcCtD
Repaglinide—Dermatitis—Propranolol—migraine	0.000558	0.00276	CcSEcCtD
Repaglinide—Diarrhoea—Verapamil—migraine	0.000557	0.00275	CcSEcCtD
Repaglinide—Palpitations—Timolol—migraine	0.000557	0.00275	CcSEcCtD
Repaglinide—Visual impairment—Topiramate—migraine	0.000546	0.0027	CcSEcCtD
Repaglinide—Hypertension—Timolol—migraine	0.000544	0.00269	CcSEcCtD
Repaglinide—Chest pain—Timolol—migraine	0.000536	0.00265	CcSEcCtD
Repaglinide—Arthralgia—Timolol—migraine	0.000536	0.00265	CcSEcCtD
Repaglinide—Erythema multiforme—Topiramate—migraine	0.000536	0.00265	CcSEcCtD
Repaglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000535	0.0161	CbGpPWpGaD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000533	0.00263	CcSEcCtD
Repaglinide—Eye disorder—Topiramate—migraine	0.00053	0.00262	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Valproic Acid—migraine	0.000526	0.0026	CcSEcCtD
Repaglinide—Cardiac disorder—Topiramate—migraine	0.000526	0.0026	CcSEcCtD
Repaglinide—Nausea—Propranolol—migraine	0.000526	0.0026	CcSEcCtD
Repaglinide—Leukopenia—Gabapentin—migraine	0.000525	0.00259	CcSEcCtD
Repaglinide—Paraesthesia—Valproic Acid—migraine	0.000519	0.00256	CcSEcCtD
Repaglinide—Palpitations—Gabapentin—migraine	0.000518	0.00256	CcSEcCtD
Repaglinide—Vomiting—Verapamil—migraine	0.000518	0.00256	CcSEcCtD
Repaglinide—Anaphylactic shock—Timolol—migraine	0.000514	0.00254	CcSEcCtD
Repaglinide—Oedema—Timolol—migraine	0.000514	0.00254	CcSEcCtD
Repaglinide—Rash—Verapamil—migraine	0.000514	0.00254	CcSEcCtD
Repaglinide—Dermatitis—Verapamil—migraine	0.000513	0.00253	CcSEcCtD
Repaglinide—Immune system disorder—Topiramate—migraine	0.000512	0.00253	CcSEcCtD
Repaglinide—Headache—Verapamil—migraine	0.00051	0.00252	CcSEcCtD
Repaglinide—Dyspepsia—Valproic Acid—migraine	0.000508	0.00251	CcSEcCtD
Repaglinide—Hypertension—Gabapentin—migraine	0.000506	0.0025	CcSEcCtD
Repaglinide—Alopecia—Topiramate—migraine	0.000501	0.00247	CcSEcCtD
Repaglinide—Arthralgia—Gabapentin—migraine	0.000499	0.00247	CcSEcCtD
Repaglinide—Chest pain—Gabapentin—migraine	0.000499	0.00247	CcSEcCtD
Repaglinide—Skin disorder—Timolol—migraine	0.000499	0.00247	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Valproic Acid—migraine	0.000499	0.00246	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000496	0.00245	CcSEcCtD
Repaglinide—Constipation—Valproic Acid—migraine	0.000494	0.00244	CcSEcCtD
Repaglinide—Erythema—Topiramate—migraine	0.000494	0.00244	CcSEcCtD
Repaglinide—Malnutrition—Topiramate—migraine	0.000494	0.00244	CcSEcCtD
Repaglinide—Nausea—Verapamil—migraine	0.000484	0.00239	CcSEcCtD
Repaglinide—KCNJ11—Type II diabetes mellitus—TNF—migraine	0.000481	0.0144	CbGpPWpGaD
Repaglinide—Oedema—Gabapentin—migraine	0.000479	0.00237	CcSEcCtD
Repaglinide—Anaphylactic shock—Gabapentin—migraine	0.000479	0.00237	CcSEcCtD
Repaglinide—Back pain—Topiramate—migraine	0.000477	0.00236	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—ESR1—migraine	0.000473	0.0142	CbGpPWpGaD
Repaglinide—Gastrointestinal pain—Valproic Acid—migraine	0.000472	0.00233	CcSEcCtD
Repaglinide—Thrombocytopenia—Gabapentin—migraine	0.000469	0.00232	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Timolol—migraine	0.000468	0.00231	CcSEcCtD
Repaglinide—Skin disorder—Gabapentin—migraine	0.000465	0.0023	CcSEcCtD
Repaglinide—Paraesthesia—Timolol—migraine	0.000462	0.00228	CcSEcCtD
Repaglinide—Urticaria—Valproic Acid—migraine	0.000459	0.00227	CcSEcCtD
Repaglinide—Abdominal pain—Valproic Acid—migraine	0.000457	0.00226	CcSEcCtD
Repaglinide—ABCC8—Neuronal System—CACNA1A—migraine	0.000456	0.0137	CbGpPWpGaD
Repaglinide—Dyspepsia—Timolol—migraine	0.000453	0.00224	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—TRPM8—migraine	0.000447	0.0135	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Timolol—migraine	0.000444	0.00219	CcSEcCtD
Repaglinide—KCNJ11—Neuronal System—CACNA1A—migraine	0.000442	0.0133	CbGpPWpGaD
Repaglinide—Leukopenia—Topiramate—migraine	0.000442	0.00218	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Gabapentin—migraine	0.000436	0.00215	CcSEcCtD
Repaglinide—Palpitations—Topiramate—migraine	0.000436	0.00215	CcSEcCtD
Repaglinide—Paraesthesia—Gabapentin—migraine	0.00043	0.00212	CcSEcCtD
Repaglinide—Hypertension—Topiramate—migraine	0.000426	0.0021	CcSEcCtD
Repaglinide—Hypersensitivity—Valproic Acid—migraine	0.000425	0.0021	CcSEcCtD
Repaglinide—Dyspepsia—Gabapentin—migraine	0.000421	0.00208	CcSEcCtD
Repaglinide—Gastrointestinal pain—Timolol—migraine	0.00042	0.00208	CcSEcCtD
Repaglinide—Arthralgia—Topiramate—migraine	0.00042	0.00208	CcSEcCtD
Repaglinide—Chest pain—Topiramate—migraine	0.00042	0.00208	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000417	0.00206	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Gabapentin—migraine	0.000413	0.00204	CcSEcCtD
Repaglinide—Constipation—Gabapentin—migraine	0.000409	0.00202	CcSEcCtD
Repaglinide—Pruritus—Valproic Acid—migraine	0.000409	0.00202	CcSEcCtD
Repaglinide—Urticaria—Timolol—migraine	0.000408	0.00202	CcSEcCtD
Repaglinide—Abdominal pain—Timolol—migraine	0.000406	0.00201	CcSEcCtD
Repaglinide—Oedema—Topiramate—migraine	0.000403	0.00199	CcSEcCtD
Repaglinide—Diarrhoea—Valproic Acid—migraine	0.000395	0.00195	CcSEcCtD
Repaglinide—Thrombocytopenia—Topiramate—migraine	0.000394	0.00195	CcSEcCtD
Repaglinide—Gastrointestinal pain—Gabapentin—migraine	0.000391	0.00193	CcSEcCtD
Repaglinide—Skin disorder—Topiramate—migraine	0.000391	0.00193	CcSEcCtD
Repaglinide—Urticaria—Gabapentin—migraine	0.00038	0.00188	CcSEcCtD
Repaglinide—Hypersensitivity—Timolol—migraine	0.000379	0.00187	CcSEcCtD
Repaglinide—Abdominal pain—Gabapentin—migraine	0.000378	0.00187	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—ESR1—migraine	0.000374	0.0112	CbGpPWpGaD
Repaglinide—Vomiting—Valproic Acid—migraine	0.000367	0.00181	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Topiramate—migraine	0.000367	0.00181	CcSEcCtD
Repaglinide—Rash—Valproic Acid—migraine	0.000364	0.0018	CcSEcCtD
Repaglinide—Dermatitis—Valproic Acid—migraine	0.000364	0.0018	CcSEcCtD
Repaglinide—Pruritus—Timolol—migraine	0.000364	0.0018	CcSEcCtD
Repaglinide—Headache—Valproic Acid—migraine	0.000362	0.00179	CcSEcCtD
Repaglinide—Paraesthesia—Topiramate—migraine	0.000362	0.00179	CcSEcCtD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—TNF—migraine	0.000355	0.0107	CbGpPWpGaD
Repaglinide—Dyspepsia—Topiramate—migraine	0.000355	0.00175	CcSEcCtD
Repaglinide—Hypersensitivity—Gabapentin—migraine	0.000353	0.00174	CcSEcCtD
Repaglinide—Diarrhoea—Timolol—migraine	0.000352	0.00174	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Topiramate—migraine	0.000348	0.00172	CcSEcCtD
Repaglinide—Constipation—Topiramate—migraine	0.000344	0.0017	CcSEcCtD
Repaglinide—Nausea—Valproic Acid—migraine	0.000343	0.00169	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.000343	0.0103	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ATP1A2—migraine	0.000339	0.0102	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ATP1A3—migraine	0.000339	0.0102	CbGpPWpGaD
Repaglinide—Pruritus—Gabapentin—migraine	0.000339	0.00167	CcSEcCtD
Repaglinide—Gastrointestinal pain—Topiramate—migraine	0.000329	0.00163	CcSEcCtD
Repaglinide—Diarrhoea—Gabapentin—migraine	0.000328	0.00162	CcSEcCtD
Repaglinide—Vomiting—Timolol—migraine	0.000327	0.00161	CcSEcCtD
Repaglinide—Rash—Timolol—migraine	0.000324	0.0016	CcSEcCtD
Repaglinide—Dermatitis—Timolol—migraine	0.000324	0.0016	CcSEcCtD
Repaglinide—Headache—Timolol—migraine	0.000322	0.00159	CcSEcCtD
Repaglinide—Urticaria—Topiramate—migraine	0.00032	0.00158	CcSEcCtD
Repaglinide—Abdominal pain—Topiramate—migraine	0.000318	0.00157	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—migraine	0.000311	0.00934	CbGpPWpGaD
Repaglinide—Nausea—Timolol—migraine	0.000305	0.00151	CcSEcCtD
Repaglinide—Vomiting—Gabapentin—migraine	0.000304	0.0015	CcSEcCtD
Repaglinide—Rash—Gabapentin—migraine	0.000302	0.00149	CcSEcCtD
Repaglinide—Dermatitis—Gabapentin—migraine	0.000302	0.00149	CcSEcCtD
Repaglinide—Headache—Gabapentin—migraine	0.0003	0.00148	CcSEcCtD
Repaglinide—Hypersensitivity—Topiramate—migraine	0.000297	0.00147	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—HTR3A—migraine	0.000288	0.00867	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—SCN1A—migraine	0.000286	0.0086	CbGpPWpGaD
Repaglinide—Pruritus—Topiramate—migraine	0.000285	0.00141	CcSEcCtD
Repaglinide—Nausea—Gabapentin—migraine	0.000284	0.0014	CcSEcCtD
Repaglinide—Diarrhoea—Topiramate—migraine	0.000276	0.00136	CcSEcCtD
Repaglinide—Vomiting—Topiramate—migraine	0.000256	0.00127	CcSEcCtD
Repaglinide—Rash—Topiramate—migraine	0.000254	0.00125	CcSEcCtD
Repaglinide—Dermatitis—Topiramate—migraine	0.000254	0.00125	CcSEcCtD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—TRPM8—migraine	0.000252	0.00759	CbGpPWpGaD
Repaglinide—Headache—Topiramate—migraine	0.000252	0.00125	CcSEcCtD
Repaglinide—PPARG—Developmental Biology—SCN2A—migraine	0.000243	0.00732	CbGpPWpGaD
Repaglinide—Nausea—Topiramate—migraine	0.000239	0.00118	CcSEcCtD
Repaglinide—PPARG—Circadian rythm related genes—NPS—migraine	0.000234	0.00703	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—SLC6A4—migraine	0.000229	0.0069	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MEF2D—migraine	0.000223	0.00669	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—HTR7—migraine	0.000201	0.00604	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000191	0.00575	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000191	0.00575	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000189	0.00569	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000184	0.00554	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—HTR3A—migraine	0.000163	0.00489	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—MTHFR—migraine	0.000154	0.00463	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—TRPM8—migraine	0.000144	0.00434	CbGpPWpGaD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—TNF—migraine	0.000141	0.00423	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NOTCH4—migraine	0.000132	0.00398	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—migraine	0.00013	0.00392	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—MTHFR—migraine	0.000122	0.00368	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—PGR—migraine	0.000121	0.00364	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CACNA1A—migraine	0.000115	0.00345	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NOTCH3—migraine	0.000113	0.00338	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CACNA1A—migraine	0.000111	0.00335	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	0.000109	0.00329	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	0.000109	0.00329	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—HTR3A—migraine	9.3e-05	0.00279	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TNF—migraine	8.57e-05	0.00258	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CACNA1A—migraine	8.23e-05	0.00247	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—TNF—migraine	8.16e-05	0.00245	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TNF—migraine	6.64e-05	0.002	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CACNA1A—migraine	6.48e-05	0.00195	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—ESR1—migraine	6.46e-05	0.00194	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH4—migraine	6.37e-05	0.00192	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PGR—migraine	5.83e-05	0.00175	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NOTCH3—migraine	5.42e-05	0.00163	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—TNF—migraine	5.27e-05	0.00158	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—MTHFR—migraine	3.8e-05	0.00114	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CACNA1A—migraine	3.72e-05	0.00112	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CACNA1A—migraine	3.7e-05	0.00111	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—MTHFR—migraine	3.68e-05	0.00111	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ESR1—migraine	3.11e-05	0.000935	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—migraine	2.95e-05	0.000886	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—MTHFR—migraine	2.72e-05	0.000818	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MTHFR—migraine	2.14e-05	0.000644	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CACNA1A—migraine	2e-05	0.000601	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTHFR—migraine	1.23e-05	0.00037	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTHFR—migraine	1.22e-05	0.000368	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTHFR—migraine	6.61e-06	0.000199	CbGpPWpGaD
